Aurorix Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: Very Common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare (≥1/10,000 to <1,000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). (See table.)

Click on icon to see table/diagram/image

When treating patients with schizophrenic or schizoaffective psychoses, exacerbation of schizophrenic symptoms may occur. If somehow possible, treatment with long-term neuroleptics should be continued in these patients (refer to Precautions).
Patients with suicidal tendencies should receive careful monitoring during the initial phase of treatment.

View ADR Reporting Link

Aurorix Adverse Reactions

moclobemide

Manufacturer:

Mylan Healthcare

Distributor:

Zuellig Pharma